Felix Frueh

Felix Frueh is a renowned professional with a strong background in pharmacology and molecular biology. He attended Stanford University where he pursued his studies in Pharmacology and later completed a Doctor of Philosophy in Molecular Biology and Biochemistry at the University of Basel.

Over the years, Felix has held key positions in various organizations, showcasing his expertise and leadership skills. He is the Co-Founder and CSO at Selva Therapeutics, Inc., where he plays a pivotal role in the company's success. Previously, he served as the Executive Partner at Opus Three LLC, Chief Executive Officer at Intellos Health LLC, and Chief Scientific Officer at Human Longevity, Inc., among others.

With a diverse professional background, Felix Frueh has also been involved in significant roles such as Entrepreneur-in-Residence at Third Rock Ventures, President of Medco Research Institute at Medco Health Solutions, Inc., and Associate Director of Genomics at FDA. His experience extends to founding and managing Stepoutside Consulting, LLC, directing Pharmacogenomics at Transgenomics, Inc., and holding academic positions like Assistant Director at Protogene Laboratories, Inc. and Assistant Professor at Georgetown University.

Felix's career highlights his deep knowledge and contributions to the fields of healthcare, genomics, and pharmaceuticals. His extensive experience in both corporate and academic settings has shaped him into a versatile and accomplished professional.